Evidence map›Paper›PMID 41063824›Full record

ArticleCase reports in ophthalmology

Catastrophic Sequelae of Corneal Melt from Severe Active Thyroid Eye Disease in a Patient with Substance Use Disorder: A Case Report.

Bahram Eshraghi, Sara KamaliZonouzi, Mohsen Pourazizi, Sarah Ghorbani

Abstract readCase Reports
In one paragraph

Article in Case reports in ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bahram EshraghiIsfahan Eye Research Center, Department of Ophthalmology, Isfahan University of Medical Sciences, Isfahan, Iran.
Sara KamaliZonouziSchool of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Mohsen PouraziziIsfahan Eye Research Center, Department of Ophthalmology, Isfahan University of Medical Sciences, Isfahan, Iran.
Sarah GhorbaniIsfahan Eye Research Center, Department of Ophthalmology, Isfahan University of Medical Sciences, Isfahan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Thyroid eye disease (TED) is a known complication of Graves' disease, but severe presentations with bilateral corneal melting ulcers are rare. Simultaneous substance use disorder might make the disease management more challenging. Case Presentation: Herein, we present a 29-year-old man with a history of Graves' disease who, despite prior hospitalization for milder symptoms, experienced a deterioration of his condition, leading to bilateral corneal melting ulcers. He was treated with fortified ophthalmic antibiotic drops, and methimazole dosage was increased. Intravenous methylprednisolone and mycophenolate mofetil were also started. Urgent orbital decompression on medial and inferior walls, canthotomy/cantholysis, and medial and lateral tarsorrhaphy were performed, followed by conjunctival flap placement and bilateral total blepharorrhaphy. Despite comprehensive treatment, the patient exhibited a poor therapeutic response and ultimately retained only light perception in both eyes. Conclusion: The patient's complex medical history including homelessness and substance abuse complicated both diagnosis and management. This case highlights the challenges in treating severe TED and underscores the importance of timely intervention and patient compliance.

Indexed as

Corneal meltingGraves’ orbitopathySubstance use disorderThyroid eye disease

Identifiers

PMID41063824
PMCPMC12503727

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.